Literature DB >> 19940000

Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.

Wiebke Ulbrich1, Alf Lamprecht.   

Abstract

Limitations in therapy induced by adverse effects due to unselective drug availability and therefore the use of potentially too high doses are a common problem. One prominent example for this dilemma are inflammatory diseases. Colloidal carriers allow one to improve delivery of drugs to the site of action and appear promising to overcome this general therapeutic drawback. Specific uptake of nanoparticles by immune-related cells in inflamed barriers offers selective drug targeting to the inflamed tissue. Here we focus on nanocarrier-based drug delivery strategies for the treatment of common inflammatory disorders like rheumatoid arthritis, multiple sclerosis, uveitis or inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940000      PMCID: PMC2843985          DOI: 10.1098/rsif.2009.0285.focus

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  97 in total

Review 1.  A new twist to the leukocyte adhesion cascade: intimate cooperation is key.

Authors:  Douglas A Steeber; Guglielmo M Venturi; Thomas F Tedder
Journal:  Trends Immunol       Date:  2005-01       Impact factor: 16.687

2.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

3.  Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate.

Authors:  P J Richards; B D Williams; A S Williams
Journal:  Rheumatology (Oxford)       Date:  2001-09       Impact factor: 7.580

Review 4.  The promise of minocycline in neurology.

Authors:  V Wee Yong; Jennifer Wells; Fabrizio Giuliani; Steven Casha; Christopher Power; Luanne M Metz
Journal:  Lancet Neurol       Date:  2004-12       Impact factor: 44.182

5.  Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats.

Authors:  Alf Lamprecht; Hiromitsu Yamamoto; Hirofumi Takeuchi; Yoshiaki Kawashima
Journal:  J Pharmacol Exp Ther       Date:  2005-06-24       Impact factor: 4.030

Review 6.  Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.

Authors:  G Filippini; F Brusaferri; W A Sibley; A Citterio; G Ciucci; R Midgard; L Candelise
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes.

Authors:  Tareq Taha Jubeh; Yechezkel Barenholz; Abraham Rubinstein
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

8.  Chitosan based nanocarriers for indomethacin ocular delivery.

Authors:  Alia A Badawi; Hanan M El-Laithy; Riad K El Qidra; Hala El Mofty; Mohamed El dally
Journal:  Arch Pharm Res       Date:  2008-09-12       Impact factor: 4.946

9.  VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo.

Authors:  Sara Gosk; Torben Moos; Claudia Gottstein; Gerd Bendas
Journal:  Biochim Biophys Acta       Date:  2008-01-05

10.  Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium.

Authors:  H Pinto-Alphandary; O Balland; M Laurent; A Andremont; F Puisieux; P Couvreur
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

View more
  35 in total

Review 1.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Cell-mediated assembly of phototherapeutics.

Authors:  Weston J Smith; Nathan P Oien; Robert M Hughes; Christina M Marvin; Zachary L Rodgers; Junghyun Lee; David S Lawrence
Journal:  Angew Chem Int Ed Engl       Date:  2014-08-22       Impact factor: 15.336

3.  Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.

Authors:  Giovanna Leoni; Philipp-Alexander Neumann; Nazila Kamaly; Miguel Quiros; Hikaru Nishio; Hefin R Jones; Ronen Sumagin; Roland S Hilgarth; Ashfaqul Alam; Gabrielle Fredman; Ioannis Argyris; Emile Rijcken; Dennis Kusters; Chris Reutelingsperger; Mauro Perretti; Charles A Parkos; Omid C Farokhzad; Andrew S Neish; Asma Nusrat
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

4.  NanoBioInterface: a multidisciplinary challenge.

Authors:  C James Kirkpatrick; William Bonfield
Journal:  J R Soc Interface       Date:  2009-12-02       Impact factor: 4.118

Review 5.  Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems.

Authors:  Daniela Placha; Josef Jampilek
Journal:  Pharmaceutics       Date:  2021-01-06       Impact factor: 6.321

Review 6.  Liposomes in tissue engineering and regenerative medicine.

Authors:  Nelson Monteiro; Albino Martins; Rui L Reis; Nuno M Neves
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

7.  Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects.

Authors:  José Lopes-de-Araújo; Ana Rute Neves; Virgínia M Gouveia; Catarina C Moura; Cláudia Nunes; Salette Reis
Journal:  Pharm Res       Date:  2015-09-09       Impact factor: 4.200

8.  Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.

Authors:  Katharina Maisel; Laura Ensign; Mihika Reddy; Richard Cone; Justin Hanes
Journal:  J Control Release       Date:  2014-11-04       Impact factor: 9.776

Review 9.  Leveraging Electrostatic Interactions for Drug Delivery to the Joint.

Authors:  Shreedevi Kumar; Blanka Sharma
Journal:  Bioelectricity       Date:  2020-06-17

10.  Novel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluation.

Authors:  Milind Alai; Wen Jen Lin
Journal:  AAPS J       Date:  2014-02-12       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.